"Every type of cancer reacts differently within your unique biological microenvironment and so our teams work together to collaborate and determine a personalized treatment plan for your individual needs. We work with both adult and pediatric patients including input from family members or caregivers, through a multi-disciplinary approach to care – meaning we bring together an entire team of specialists for healthcare decisions. Knowing each patient has different goals and objectives, the Georgia Cancer Center also has an entire support network to help you every step of the way. As a patient at the Georgia Cancer Center, you will have the support of an entire multi-disciplinary team of cancer specialists."

During the past decade, MBCCOP - Medical College of Georgia Cancer Center conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 48 clinical trials were completed, i.e. on average, 88.9% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 15 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MBCCOP - Medical College of Georgia Cancer Center" #1 sponsor was "Children's Oncology Group" with 37 trials, followed by "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "NSABP Foundation Inc" with 8 trials sponsored, "Celgene" with 5 trials sponsored and "Gynecologic Oncology Group" with 5 trials sponsored. Other sponsors include 81 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MBCCOP - Medical College of Georgia Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 90 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Children's Oncology Group" with 3 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "MBCCOP - Medical College of Georgia Cancer Center" are "Breast Cancer" (22 trials), "Leukemia" (15 trials), "Sarcoma" (14 trials), "Lymphoma" (8 trials) and "Neuroblastoma" (7 trials). Many other conditions were trialed in "MBCCOP - Medical College of Georgia Cancer Center" in a lesser frequency.

Most popular intervention types in "MBCCOP - Medical College of Georgia Cancer Center" are "Drug" (141 trials), "Biological" (32 trials), "Other" (27 trials), "Procedure" (21 trials) and "Radiation" (19 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (23 trials), "filgrastim" (17 trials), "placebo" (16 trials), "vincristine sulfate" (16 trials) and "etoposide" (15 trials). Other intervention names were less common.

The vast majority of trials in "MBCCOP - Medical College of Georgia Cancer Center" are 124 trials for "All" genders, 32 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "MBCCOP - Medical College of Georgia Cancer Center". 1 are not yet recruiting, 16 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 109 completed trials in MBCCOP - Medical College of Georgia Cancer Center, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in MBCCOP - Medical College of Georgia Cancer Center, 35 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 4 trials that are defined as “Not Applicable".